put Our Experience to work for you
Expand the reach of your studies and find the right population using our global experience to help inform your portfolio and feasibility decisions.
we have a worldwide presence
Click on a highlighted country, state or pin to see details of our experience in that area, or to see our reach for a specific therapeutic area, select it from the dropdown menu.
Data current as of April 1, 2023. The boundaries and names on this map do not imply official endorsement or acceptance by FHI Clinical.
FHI Clinical Presence
FHI Clinical & FHI 360
FHI 360 Locations
We are localized
We know how to navigate location-specific challenges so you can be prepared for any circumstance regardless of study location.
FHI Clinical has the local resources and experience to keep your study moving forward: engage with the local communities, work with still-developing regulatory agencies, ramp up quickly for an outbreak, implement contingency plans for natural disasters or political unrest and more.
Successfully implementing studies in complex settings requires an understanding of and respect for the local communities.
Our far-reaching, in-country technical, regulatory and cultural knowledge has been developed over our long history of working globally.
Our experience helps us guide decisions about the best-fit countries and populations for your target indication.
We’ve been involved in observational studies, behavioral studies and clinical trials for epidemiology, spatial repellents, vaccines and treatments in 32 African countries.
FHI Clinical offices and 361 staff members are located in 7 countries throughout Africa.
Our research involvement has included a range of non-communicable diseases as well as infectious diseases.
WE SUPPORT MANY THERAPEUTIC AREAS
We have a proven history of working to address challenges across nearly 20 therapeutic areas and 483 studies in both adult and pediatric populations:
SPECIFIC INFECTIOUS DISEASE EXPERTISE
Our team is particularly passionate about addressing infectious diseases, neglected tropical diseases and emerging and reemerging diseases in vulnerable populations. Our experience spans 308 studies across 37 indications:
we are globally connected
Access the skill sets necessary to quickly and efficiently combat disease.
Sustainable relationships with key partners ensure proactive disease management as well as rapid responses to immediate needs.
Reducing the global disease burden is only possible when we pool our resources and skills. We have collaborative partnerships with: